QT
KYMR icon

Quantbot Technologies’s Kymera Therapeutics KYMR Stock Holding History

Quantbot Technologies’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,798
Closed -$150K – 2091
2026
Q1 		$150K Buy
1,798
+1,750
+3,646% +$139K 0.01% 1238
2025
Q4 		$3.73K Buy
+48
New +$3.24K ﹤0.01% 1629
2025
Q3 		– Sell
-76
Closed -$3.32K – 1951
2025
Q2 		$3.32K Buy
+76
New +$2.62K ﹤0.01% 1567
2022
Q4 		– Sell
-6,589
Closed -$143K – 1903
2022
Q3 		$143K Buy
+6,589
New +$174K 0.01% 998
2022
Q2 		– Sell
-1,500
Closed -$63K – 1930
2022
Q1 		$63K Buy
1,500
+200
+15% +$8.45K 0.01% 1148
2021
Q4 		$82K Buy
1,300
+300
+30% +$17.5K 0.01% 916
2021
Q3 		$58K Buy
+1,000
New +$58K ﹤0.01% 1079

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Quantbot Technologies's KYMR Position: Q2 2026 in Review

Quantbot Technologies sold out of Kymera Therapeutics (KYMR) in Q2 2026, closing a stake of 1,798 shares — an estimated $150K sold.

Quantbot Technologies first reported a position in KYMR in Q3 2021 and held it in 7 quarters. The position peaked at $150K in Q1 2026. 275 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Quantbot Technologies reported no remaining Kymera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 1,798 Kymera Therapeutics shares in Q2 2026, an estimated $150K.
  • Quantbot Technologies first reported a position in Kymera Therapeutics in Q3 2021 and held it in 7 quarters.
  • Quantbot Technologies's Kymera Therapeutics position peaked at $150K in Q1 2026.
  • 275 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.